| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8944552 | Journal of the American Academy of Dermatology | 2018 | 28 Pages |
Abstract
Many subjects with CARD14 mutations display characteristics of both psoriasis and PRP. We propose the term CARD14-associated papulosquamous eruption to describe this spectrum of disease. Subjects with clinical features suggestive of CAPE should undergo CARD14 sequencing and may benefit from treatment with ustekinumab.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Brittany G. MD, Lynn M. PhD, Ronghua MD, Marie MD, John MD, Gabriela MD, Catherine MD, PhD, Paula MD, Margarita MD, PhD, Stephen MD, Kristen E. MD, Marcia MD, Benjamin MD, Bruno MD, Esteban MD, Beth MD, Kelly M. MD, Anne M. PhD, Keith A. MD, PhD,